Innovation Fails Because of Corporate Antibodies

Innovation Fails Because of Corporate AntibodiesHere’s a big reason why open innovation efforts can fail: they are often killed by corporate antibodies resisting the changes brought by opening up to external partners. These antibodies can exist in both large and small companies. If you’re hearing statements such as these, corporate antibodies may be at hard at work, resisting change.. Continue reading
This entry was posted in Leadership and tagged . Bookmark the permalink.

Comments are closed.